IGC Pharma, Inc. — Investor Relations & Filings
Filings indexed
762
across all filing types
Latest filing
2026-04-20
Regulatory Filings
Country
US
United States of America
Listing
US
IGC
IGC Pharma, Inc. is a clinical-stage biotechnology company focused on developing treatments for Alzheimer's disease. The company leverages artificial intelligence (AI) in its development process. Its lead candidate, IGC-AD1, is being evaluated in a Phase 2 clinical trial for treating agitation in patients with dementia due to Alzheimer's. The company's pipeline also includes TGR-63, a pre-clinical small molecule designed to inhibit amyloid plaque aggregation. Supporting its therapeutic development is MINT-AD, an AI-powered platform for the early detection of Alzheimer's and to improve the understanding of disease progression.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-04-20 | English | |
| 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-30 | English | |
| 10-KT - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-18 | English | |
| 4 Filing | 2026-02-04 | English | |
| 4 Filing | 2026-01-20 | English | |
| 8-K - IGC PHARMA, INC. (0001326205) (Filer) | 2026-01-06 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 34693717 | 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-04-20 | English | ||
| 33093350 | 8-K - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-30 | English | ||
| 32979091 | 10-KT - IGC Pharma, Inc. (0001326205) (Filer) | 2026-03-18 | English | ||
| 28898684 | 4 Filing | 2026-02-04 | English | ||
| 28898699 | 4 Filing | 2026-01-20 | English | ||
| 32890161 | 8-K - IGC PHARMA, INC. (0001326205) (Filer) | 2026-01-06 | English | ||
| 11848719 | FORM 8-K | 2026-01-02 | English | ||
|
2025
8 filings
| |||||
| 11848724 | FORM 8-K | 2025-12-15 | English | ||
| 11848723 | Regulatory Filings 2025 | 2025-12-08 | English | ||
| 11848725 | FORM S-3/A | 2025-12-03 | English | ||
| 11848731 | FORM S-3 | 2025-11-14 | English | ||
| 11848732 | FORM S-8 | 2025-11-14 | English | ||
| 11848730 | FORM 10-Q | 2025-11-14 | English | ||
| 11848726 | FORM 8-K | 2025-11-14 | English | ||
| 11848727 | Director's Dealing 2025 | 2025-10-22 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Atara Biotherapeutics, Inc.
Develops off-the-shelf allogeneic T-cell immunotherapies fo…
|
ATRA | US | Professional, scientific and te… |
|
ATUM CO., LTD.
An integrated biologics development partner offering servic…
|
355690 | KR | Professional, scientific and te… |
|
AUREKA LIMITED
Accelerates drug discovery and development using AI and com…
|
AKA | AU | Professional, scientific and te… |
|
Avalo Therapeutics, Inc.
Clinical-stage biotech developing treatments for immune-med…
|
AVTX | US | Professional, scientific and te… |
|
Azenta, Inc.
Offers sample management, storage, and multiomics solutions…
|
AZTA | US | Professional, scientific and te… |
|
Baijin Life Science Holdings Limited
An investment holding company operating in biopharmaceutica…
|
1466 | HK | Professional, scientific and te… |
|
BCAL DIAGNOSTICS LIMITED
Developing a non-invasive blood test for early breast cance…
|
BDX | AU | Professional, scientific and te… |
|
BEBETTER MED INC.
Develops small molecule therapeutics for oncology, metaboli…
|
688759 | CN | Professional, scientific and te… |
|
Beijing Sun-Novo Pharmaceutical Research Co.,Ltd.
Integrated CRO providing full-spectrum R&D from drug discov…
|
688621 | CN | Professional, scientific and te… |
|
BenevolentAI
Applies artificial intelligence to accelerate drug discover…
|
BAI | LU | Professional, scientific and te… |
IGC Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34705/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34705 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34705 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34705 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34705}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IGC Pharma, Inc. (id: 34705)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.